Filtered By:
Drug: Prozac
This page shows you your search results in order of date. This is page number 8.
Order by Relevance | Date
Total 193 results found since Jan 2013.
Meta-analysis of the clinical effectiveness of combined acupuncture and Western Medicine to treat post-stroke depression
CONCLUSION: The therapeutic effects of acupuncture combined with Western Medicine on post-stroke depression are often better than those of Western Medicine alone, and fewer adverse reactions occur. However, more high-quality RCTs are needed to further confirm these findings.PMID:33522192 | DOI:10.19852/j.cnki.jtcm.2021.01.002
Source: Journal of Traditional Chinese Medicine - February 1, 2021 Category: Complementary Medicine Authors: Xue Wang Jun Xiong Jun Yang Ting Yuan Yunfeng Jiang Xiaohong Zhou Kai Liao Lingling Xu Source Type: research
Meta-analysis of the clinical effectiveness of combined acupuncture and Western Medicine to treat post-stroke depression.
CONCLUSION: The therapeutic effects of acupuncture combined with Western Medicine on post-stroke depression are often better than those of Western Medicine alone, and fewer adverse reactions occur. However, more high-quality RCTs are needed to further confirm these findings.
PMID: 33522192 [PubMed - in process]
Source: Journal of Traditional Chinese Medicine - February 1, 2021 Category: Complementary Medicine Authors: Wang X, Xiong J, Yang J, Yuan T, Jiang Y, Zhou X, Liao K, Xu L Tags: J Tradit Chin Med Source Type: research
Fluoxetine for stroke recovery improvement - the doubleblind, randomised placebo-controlled FOCUS-Poland trial.
CONCLUSIONS AND CLINICAL IMPLICATIONS: Consistent with other trials based on the FOCUS protocol, fluoxetine did not improve motor recovery or general stroke outcome at six and 12 months in the Polish cohort studied. However, patients receiving fluoxetine required therapy with additional antidepressant medication less frequently.
PMID: 33373036 [PubMed - as supplied by publisher]
Source: Neurologia i Neurochirurgia Polska - December 29, 2020 Category: Neurology Authors: Bembenek JP, Niewada M, Kłysz B, Mazur A, Kurczych K, Głuszkiewicz M, Członkowska A Tags: Neurol Neurochir Pol Source Type: research
Update to the FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: statistical analysis plan for the trials and for the individual patient data meta-analysis
Three large trials of fluoxetine for stroke recovery (FOCUS (fluoxetine or control under supervision), AFFINITY (the Assessment oF FluoxetINe In sTroke recovery) and EFFECTS (Efficacy oF Fluoxetine —a randomisE...
Source: Trials - November 25, 2020 Category: General Medicine Authors: Gillian Elizabeth Mead, Catriona Graham, Laurent Billot, Per N äsman, Erik Lundström, Steff Lewis, Graeme J. Hankey, Maree L. Hackett, John Forbes and Martin Dennis Tags: Update Source Type: research
Fluoxetine-induced recovery of serotonin and norepinephrine projections in a mouse model of post-stroke depression
Translational Psychiatry, Published online: 30 September 2020; doi:10.1038/s41398-020-01008-9Fluoxetine-induced recovery of serotonin and norepinephrine projections in a mouse model of post-stroke depression
Source: Translational Psychiatry - September 29, 2020 Category: Psychiatry Authors: Amin Zahrai Faranak Vahid-Ansari Mireille Daigle Paul R. Albert Source Type: research
Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial - AFFINITY Trial Collaboration.
BACKGROUND: Trials of fluoxetine for recovery after stroke report conflicting results. The Assessment oF FluoxetINe In sTroke recoverY (AFFINITY) trial aimed to show if daily oral fluoxetine for 6 months after stroke improves functional outcome in an ethni...
Source: SafetyLit - July 27, 2020 Category: International Medicine & Public Health Tags: Falls Source Type: news
Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial
Publication date: August 2020Source: The Lancet Neurology, Volume 19, Issue 8Author(s): Erik Lundström, Eva Isaksson, Per Näsman, Per Wester, Björn Mårtensson, Bo Norrving, Håkan Wallén, Jörgen Borg, Martin Dennis, Gillian Mead, Graeme J Hankey, Maree L Hackett, Katharina S Sunnerhagen
Source: The Lancet Neurology - July 21, 2020 Category: Neurology Source Type: research
Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial
Publication date: August 2020Source: The Lancet Neurology, Volume 19, Issue 8Author(s): Graeme J. Hankey, Maree L. Hackett, Osvaldo P. Almeida, Leon Flicker, Gillian E. Mead, Martin S. Dennis, Christopher Etherton-Beer, Andrew H. Ford, Laurent Billot, Stephen Jan, Thomas Lung, Veronica Murray, Erik Lundström, Craig S. Anderson, Robert Herbert, Gregory Carter, Geoffrey A. Donnan, Huy-Thang Nguyen, John Gommans, Qilong Yi
Source: The Lancet Neurology - July 21, 2020 Category: Neurology Source Type: research
Wrist-ankle acupuncture and Fluoxetine in the treatment of post-stroke depression: a randomized controlled clinical trial.
CONCLUSION: The present study showed that WAA combined with fluoxetine can relieve the symptoms of depression after stroke. WAA therapy could improve the antidepressant effect of fluoxetine.
PMID: 32506860 [PubMed - in process]
Source: Journal of Traditional Chinese Medicine - May 31, 2020 Category: Complementary Medicine Authors: You Y, Zhang T, Shu S, Qian X, Zhou S, Yao F Tags: J Tradit Chin Med Source Type: research
Fluoxetine Disappoints in Two New Stroke Trials Fluoxetine Disappoints in Two New Stroke Trials
The antidepressant failed to yield improvements in stroke recovery and was associated with an increase in fracture rates in the EFFECTS and AFFINITY studies.Medscape Medical News
Source: Medscape Psychiatry Headlines - May 14, 2020 Category: Psychiatry Tags: Neurology & Neurosurgery News Source Type: news
